Elizabeth Heinlein, CNM | |
2500 English Creek Ave, Egg Harbor Township, NJ 08234-5549 | |
(609) 407-2300 | |
Not Available |
Full Name | Elizabeth Heinlein |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 2500 English Creek Ave, Egg Harbor Township, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982345237 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 25ME00078000 (New Jersey) | Secondary |
367A00000X | Advanced Practice Midwife | 25ME00078001 (New Jersey) | Primary |
Entity Name | Atlanticare Physician Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093829608 PECOS PAC ID: 8527953660 Enrollment ID: O20040218000405 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has agreed to the Company's proposed amendment to the Phase 3 AFFINITY protocol and statistical analysis plan.
The American Cancer Society and the Clinton Health Access Initiative (CHAI) today announced agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. Purchasers are expected to save an average of 59 percent for medicines procured through the agreements.
Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years.
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Gilead Sciences, Inc. today announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa® (ranolazine extended-release tablets). The lawsuit is based on an Abbreviated New Drug Application filed by Lupin, which seeks approval to manufacture and market a generic version of Ranexa before the expiration of Gilead's Ranexa patents.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Elizabeth Heinlein, CNM 2500 English Creek Ave, Egg Harbor Township, NJ 08234-5549 Ph: () - | Elizabeth Heinlein, CNM 2500 English Creek Ave, Egg Harbor Township, NJ 08234-5549 Ph: (609) 407-2300 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has agreed to the Company's proposed amendment to the Phase 3 AFFINITY protocol and statistical analysis plan.
The American Cancer Society and the Clinton Health Access Initiative (CHAI) today announced agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. Purchasers are expected to save an average of 59 percent for medicines procured through the agreements.
Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years.
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Gilead Sciences, Inc. today announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa® (ranolazine extended-release tablets). The lawsuit is based on an Abbreviated New Drug Application filed by Lupin, which seeks approval to manufacture and market a generic version of Ranexa before the expiration of Gilead's Ranexa patents.
› Verified 6 days ago
Audrey Charlotte Kingman, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 1000, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 | |
Ms. Jeanne Marie Dadura, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 1000, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 Fax: 609-677-7210 | |
Susan Marie Armitage, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 1000, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 Fax: 609-677-7210 | |
Mrs. Rose Madeleine Scaffidi, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 200, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 | |
Briana Rainey, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave Ste 1000, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 | |
Miss Angelia Kae Flipping, CNM-FA, MSN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2500 English Creek Ave, Suite 214, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 Fax: 609-677-7210 | |
Jamie Sosa, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2500 English Creek Ave, Sutie 214, Egg Harbor Township, NJ 08234 Phone: 609-677-7211 Fax: 609-677-7210 |